280 related articles for article (PubMed ID: 20099461)
1. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
Kalonia H; Kumar P; Nehru B; Kumar A
Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
3. Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
Kalonia H; Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):607-15. PubMed ID: 21237233
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Kalonia H; Kumar P; Kumar A
Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
[TBL] [Abstract][Full Text] [Related]
5. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
6. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
Kalonia H; Kumar P; Kumar A
Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neurotoxicology; 2010 Mar; 31(2):195-203. PubMed ID: 20043943
[TBL] [Abstract][Full Text] [Related]
8. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
9. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
[TBL] [Abstract][Full Text] [Related]
10. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):100-8. PubMed ID: 19022325
[TBL] [Abstract][Full Text] [Related]
11. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.
Velloso NA; Dalmolin GD; Fonini G; Gindri Sinhorin VD; Ferreira da Silveira A; Rubin MA; Mello CF
Brain Res; 2008 Mar; 1198():107-14. PubMed ID: 18243165
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain.
Gaur V; Aggarwal A; Kumar A
Eur J Pharmacol; 2009 Aug; 616(1-3):147-54. PubMed ID: 19577560
[TBL] [Abstract][Full Text] [Related]
13. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
Kalonia H; Kumar P; Kumar A
Brain Res; 2011 Feb; 1372():115-26. PubMed ID: 21112316
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
17. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
18. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of dapsone against quinolinate- and kainate-induced striatal neurotoxicities in rats.
Santamaría A; Ordaz-Moreno J; Rubio-Osornio M; Solís-Hernández F; Ríos C
Pharmacol Toxicol; 1997 Dec; 81(6):271-5. PubMed ID: 9444668
[TBL] [Abstract][Full Text] [Related]
20. Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats.
Kalonia H; Kumar P; Kumar A
Eur J Pharmacol; 2010 May; 634(1-3):46-52. PubMed ID: 20188726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
